CINAP is a key player in cellular signaling, primarily through its role in the cyclic nucleotide pathway. As a central component in the modulation of cyclic AMP (cAMP) and cyclic GMP (cGMP) concentrations within cells, CINAP's expression and activity are critical for maintaining the delicate balance of intracellular signaling cascades. These signaling pathways are crucial for a multitude of cellular functions, including but not limited to, metabolic regulation, gene transcription, and cell cycle progression. The expression of CINAP itself is subject to regulation by various intracellular signals and can be influenced by external molecular activators. Such activators can induce the expression of CINAP through diverse mechanisms, often involving the alteration of intracellular second messenger levels, which in turn can have downstream effects on the expression of a range of genes, including those encoding for CINAP.
A range of chemical activators is known to potentially induce the expression of CINAP by targeting different aspects of the cyclic nucleotide pathways. Compounds like forskolin, for example, directly target adenylyl cyclase, leading to a significant increase in cAMP levels and potentially upregulating CINAP expression. On the other hand, phosphodiesterase inhibitors such as IBMX, rolipram, and sildenafil act by preventing the breakdown of cAMP or cGMP, thereby sustaining their levels within the cell and creating a conducive environment for the induction of CINAP. Other activators, such as vinpocetine and dipyridamole, exert their effects by selectively inhibiting specific phosphodiesterase enzymes, resulting in elevated levels of these cyclic nucleotides, which may trigger a cascade of intracellular events culminating in the increased expression of CINAP. It's worth noting that the mechanisms by which these chemicals induce CINAP expression are complex and depend on the interplay between various signaling molecules and pathways. The interdependency of these pathways highlights the intricate web of cellular regulation and underscores the potential of diverse small molecules to modulate the expression of key regulatory proteins such as CINAP.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, markedly increasing intracellular cAMP levels, which may upregulate CINAP expression due to enhanced cAMP-dependent signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol binds to beta-adrenergic receptors and prompts a surge in cAMP production, potentially stimulating the transcription of genes including that of CINAP. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX maintains elevated intracellular cAMP and cGMP by inhibiting their degradation, thereby creating an environment that could promote the transcriptional activation of CINAP. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram selectively inhibits PDE4, leading to increased cAMP levels within cells, which can initiate a signaling cascade resulting in the upregulation of CINAP. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
Cilostamide, by selectively inhibiting PDE3, causes an increase in cAMP concentrations, which may trigger a signaling cascade culminating in the induction of CINAP expression. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Zaprinast, as a PDE5 inhibitor, raises cGMP levels, which could trigger downstream signaling pathways that stimulate CINAP expression. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $31.00 $83.00 | 6 | |
Theophylline induces elevated levels of cAMP and cGMP due to its nonselective phosphodiesterase inhibitory activity, which could lead to an increase in CINAP expression. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine inhibits PDE1, leading to higher cAMP and cGMP levels, which could translate into the transcriptional activation of CINAP. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $30.00 $100.00 | 1 | |
Dipyridamole, by inhibiting various phosphodiesterases, causes cAMP and cGMP to accumulate, which may result in a heightened transcriptional response including the upregulation of CINAP. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxifylline suppresses phosphodiesterase activity, thus causing an increase in cAMP, which could lead to the induction of CINAP expression through enhanced signaling pathways. |